NCR1 and prostate carcinoma: Thus, downregulation of the ligand might be an escape mechanism of the tumor to evade NK cell cytotoxicity, and inversely our results suggest that upregulation of the NK cell receptors- notably NKp46, in some long-responders patients, could favor tumor control in prostate cancer.